Regulation of Breast Cancer and Bone Metastasis by MicroRNAs

Breast cancer progression including bone metastasis is a complex process involving numerous changes in gene expression and function. MicroRNAs (miRNAs) are small endogenous noncoding RNAs that regulate gene expression by targeting protein-coding mRNAs posttranscriptionally, often affecting a number of gene targets simultaneously. Alteration in expression of miRNAs is common in human breast cancer, possessing with either oncogenic or tumor suppressive activity. The expression and the functional role of several miRNAs (miR-206, miR-31, miR-27a/b, miR-21, miR-92a, miR-205, miR-125a/b, miR-10b, miR-155, miR-146a/b, miR-335, miR-204, miR-211, miR-7, miR-22, miR-126, and miR-17) in breast cancer has been identified. In this review we summarize the experimentally validated targets of up- and downregulated miRNAs and their regulation in breast cancer and bone metastasis for diagnostic and therapeutic purposes.

[1]  Caixia Liu,et al.  Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen , 2011, Oncogene.

[2]  M. Salto‐Tellez,et al.  Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer. , 2009, European journal of cancer.

[3]  Xu Ma,et al.  MiR-125b Expression Affects the Proliferation and Apoptosis of Human Glioma Cells by Targeting Bmf , 2009, Cellular Physiology and Biochemistry.

[4]  Jing Lin,et al.  MiR-21 plays an Important Role in Radiation Induced Carcinogenesis in BALB/c Mice by Directly Targeting the Tumor Suppressor Gene Big-h3 , 2011, International journal of biological sciences.

[5]  近藤 直人.  miR-206 expression is down-regulated in estrogen receptor α-positive human breast cancer , 2009 .

[6]  Robert A. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer (Nature (2007) 449, (682-688)) , 2008 .

[7]  Shuomin Zhu,et al.  MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)* , 2007, Journal of Biological Chemistry.

[8]  H. Kung,et al.  microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs , 2009, Brain Research.

[9]  L. Naldini,et al.  A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. , 2013, Blood.

[10]  T. Wurdinger,et al.  MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators , 2008, Molecular and Cellular Biology.

[11]  M. J. Simard,et al.  A new twist in the microRNA pathway: Not Dicer but Argonaute is required for a microRNA production , 2010, Cell Research.

[12]  G. Stein,et al.  Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone , 2006, Cancer and Metastasis Reviews.

[13]  Y. Mo,et al.  Systematic validation of predicted microRNAs for cyclin D1 , 2009, BMC Cancer.

[14]  A. Papanikolaou,et al.  Cyclin D1 in breast cancer pathogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Qu,et al.  MicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma Development* , 2009, The Journal of Biological Chemistry.

[16]  Shuai Jiang,et al.  MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. , 2010, Cancer research.

[17]  Lei Shi,et al.  MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation , 2010, Brain Research.

[18]  G. Goodall,et al.  Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells , 2010, The Journal of Biological Chemistry.

[19]  Amar Deep Sharma,et al.  MicroRNAs control hepatocyte proliferation during liver regeneration , 2010, Hepatology.

[20]  H. Lodish,et al.  MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA , 2012, Haematologica.

[21]  N. Selvamurugan,et al.  Expression of microRNA-30c and its target genes in human osteoblastic cells by nano-bioglass ceramic-treatment. , 2013, International journal of biological macromolecules.

[22]  N. Colburn,et al.  A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation , 2001, Oncogene.

[23]  J. Selkirk,et al.  Regulation of microfilament organization and anchorage-independent growth by tropomyosin 1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Xiaolong Yang,et al.  MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. , 2010, The American journal of pathology.

[25]  E. Flemington,et al.  MicroRNA miR-155 Inhibits Bone Morphogenetic Protein (BMP) Signaling and BMP-Mediated Epstein-Barr Virus Reactivation , 2010, Journal of Virology.

[26]  Hongmei Ding,et al.  MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells , 2010, Molecular and Cellular Biochemistry.

[27]  S. Alahari,et al.  ST14 (Suppression of Tumorigenicity 14) Gene Is a Target for miR-27b, and the Inhibitory Effect of ST14 on Cell Growth Is Independent of miR-27b Regulation* , 2009, The Journal of Biological Chemistry.

[28]  John A. Robinson,et al.  Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. , 2003, Cancer research.

[29]  Christopher P Evans,et al.  An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells , 2007, Proceedings of the National Academy of Sciences.

[30]  R. Hartley,et al.  MicroRNA-125a represses cell growth by targeting HuR in breast cancer , 2009, RNA biology.

[31]  Anton P. McCaffrey,et al.  MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[32]  M. Salto‐Tellez,et al.  Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility , 2010, Breast Cancer Research.

[33]  Jennifer E. Van Eyk,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2016 .

[34]  R. Shiekhattar,et al.  MicroRNA biogenesis: isolation and characterization of the microprocessor complex. , 2006, Methods in molecular biology.

[35]  Francis L Martin,et al.  CYP1B1 and hormone-induced cancer. , 2012, Cancer letters.

[36]  Zhenghe Wang,et al.  microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. , 2009, Cancer research.

[37]  Michel C Nussenzweig,et al.  MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. , 2008, Immunity.

[38]  S. Jeng,et al.  Identification of the potential target genes of microRNA-146a induced by PMA treatment in human microvascular endothelial cells. , 2010, Experimental cell research.

[39]  Ming Yi,et al.  The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts , 2010, Cell cycle.

[40]  C. Croce,et al.  microRNA-205 regulates HER3 in human breast cancer. , 2009, Cancer research.

[41]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[42]  F. Maurer,et al.  The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Zekri,et al.  MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[44]  G. Stein,et al.  A microRNA signature for a BMP2-induced osteoblast lineage commitment program , 2008, Proceedings of the National Academy of Sciences.

[45]  Filip Pattyn,et al.  The microRNA body map: dissecting microRNA function through integrative genomics , 2011, Nucleic acids research.

[46]  D. Kuang,et al.  MicroRNA-155 Regulates Inflammatory Cytokine Production in Tumor-associated Macrophages via Targeting C/EBPβ , 2009, Cellular and Molecular Immunology.

[47]  M. Hanna,et al.  Role of miR-10b in breast cancer metastasis , 2010, Breast Cancer Research.

[48]  H. Hollema,et al.  Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma , 2009, BMC Cancer.

[49]  Liang Chen,et al.  Role of Deregulated microRNAs in Breast Cancer Progression Using FFPE Tissue , 2013, PloS one.

[50]  David W. Taylor,et al.  A Novel miRNA Processing Pathway Independent of Dicer Requires Argonaute2 Catalytic Activity , 2010, Science.

[51]  Jason I. Herschkowitz,et al.  The ups and downs of miR-205: Identifying the roles of miR-205 in mammary gland development and breast cancer , 2010, RNA biology.

[52]  C. Hother,et al.  Onco-miR-155 targets SHIP1 to promote TNFα-dependent growth of B cell lymphomas , 2009, EMBO molecular medicine.

[53]  S. Chiou,et al.  miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. , 2010, Cancer research.

[54]  Shingo Takagi,et al.  MicroRNA regulates the expression of human cytochrome P450 1B1. , 2006, Cancer research.

[55]  Q. Pan,et al.  MicroRNA‐125b suppresses the development of bladder cancer by targeting E2F3 , 2011, International journal of cancer.

[56]  Y. Tomari,et al.  Multilayer checkpoints for microRNA authenticity during RISC assembly , 2011, EMBO reports.

[57]  R. Weinberg,et al.  Activation of miR-31 function in already-established metastases elicits metastatic regression. , 2011, Genes & development.

[58]  Oliver Hofmann,et al.  miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. , 2009, Molecular cell.

[59]  G. Hannon,et al.  miRNAs on the move: miRNA biogenesis and the RNAi machinery. , 2004, Current opinion in cell biology.

[60]  Min Liu,et al.  Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma , 2009, Cell Research.

[61]  J. Gudmundsson,et al.  Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. , 1998, European journal of cancer.

[62]  G. Stein,et al.  Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Eytan Domany,et al.  Atom-efficient synthesis of 2,4,6-trisubstituted 1,3,5-triazines via Fe-catalyzed cyclization of aldehydes with NH4I as the sole nitrogen source , 2020, RSC advances.

[64]  Domenico Coppola,et al.  MicroRNA-155 Regulates Cell Survival, Growth, and Chemosensitivity by Targeting FOXO3a in Breast Cancer* , 2010, The Journal of Biological Chemistry.

[65]  C. Benz,et al.  Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies , 2006, Molecular Cancer.

[66]  Kedar S Vaidya,et al.  Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. , 2009, Cancer research.

[67]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[68]  Li Wang,et al.  MicroRNA-206 Targets notch3, Activates Apoptosis, and Inhibits Tumor Cell Migration and Focus Formation* , 2009, The Journal of Biological Chemistry.

[69]  Terry Hyslop,et al.  A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation , 2008, The Journal of cell biology.

[70]  G. Stein,et al.  MicroRNA control of bone formation and homeostasis , 2012, Nature Reviews Endocrinology.

[71]  Wei Liu,et al.  MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. , 2008, Cancer letters.

[72]  J. Mattick,et al.  Genome research , 1990, Nature.

[73]  Gonzalo Gómez-López,et al.  Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway , 2012, Breast Cancer Research and Treatment.

[74]  D. Liao,et al.  c-Myc in breast cancer. , 2000, Endocrine-related cancer.

[75]  Massimo Negrini,et al.  Breast cancer metastasis: a microRNA story , 2008, Breast Cancer Research.

[76]  K. Gopinath,et al.  Oncogenic MicroRNA-155 Down-regulates Tumor Suppressor CDC73 and Promotes Oral Squamous Cell Carcinoma Cell Proliferation , 2012, The Journal of Biological Chemistry.

[77]  R. Göke,et al.  The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation , 2009, Biology of the cell.

[78]  Q. Pan,et al.  microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells , 2009, Molecular human reproduction.

[79]  C. Bracken,et al.  Mutant p53 drives invasion in breast tumors through up-regulation of miR-155 , 2013, Oncogene.

[80]  N. Kondo,et al.  miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. , 2009, Cancer research.

[81]  K. Khalili,et al.  CCL8/MCP‐2 is a target for mir‐146a in HIV‐1‐infected human microglial cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  I. Bozzoni,et al.  Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells , 2008, The EMBO journal.

[83]  S. Orkin,et al.  miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. , 2010, Genes & development.

[84]  George A Calin,et al.  Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer. , 2013, Cancer research.

[85]  A. Burny,et al.  Human natural Treg microRNA signature: Role of microRNA‐31 and microRNA‐21 in FOXP3 expression , 2009, European journal of immunology.

[86]  David Smith,et al.  A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. , 2009, Cancer research.

[87]  T. Sellers,et al.  Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer , 2013, Oncogene.

[88]  A. Dopazo,et al.  miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells , 2011, Cell Death and Differentiation.

[89]  R. García-Becerra,et al.  Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance , 2012, International journal of molecular sciences.

[90]  P. Guyre,et al.  Estradiol Suppresses NF-κB Activation through Coordinated Regulation of let-7a and miR-125b in Primary Human Macrophages , 2010, The Journal of Immunology.

[91]  A. Jimeno,et al.  The development of regorafenib and its current and potential future role in cancer therapy. , 2013, Drugs of today.

[92]  Sijin Liu,et al.  Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. , 2009, Cancer research.

[93]  H. Allgayer,et al.  MicroRNAs-10a and -10b Contribute to Retinoic Acid-induced Differentiation of Neuroblastoma Cells and Target the Alternative Splicing Regulatory Factor SFRS1 (SF2/ASF)* , 2010, The Journal of Biological Chemistry.

[94]  C. Croce,et al.  Oncosuppressive role of p53‐induced miR‐205 in triple negative breast cancer , 2012, Molecular oncology.

[95]  Jing Zhao,et al.  17β-Estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells , 2013, Molecular and Cellular Biochemistry.

[96]  Yong Li,et al.  A novel miR‐155/miR‐143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells , 2012, The EMBO journal.

[97]  Hailong Wu,et al.  Suppression of cell growth and invasion by miR-205 in breast cancer , 2008, Cell Research.

[98]  S. Safe,et al.  MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells. , 2010, Endocrinology.

[99]  Yi Liu,et al.  miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma. , 2011, Urology.

[100]  Danish Sayed,et al.  MicroRNAs in development and disease. , 2011, Physiological reviews.

[101]  Michael A. Freitas,et al.  In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation , 2013, The Journal of experimental medicine.

[102]  Shuomin Zhu,et al.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis , 2008, Cell Research.

[103]  Stephen Safe,et al.  The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. , 2007, Cancer research.

[104]  Ahmedin Jemal,et al.  Breast cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[105]  Hailong Wu,et al.  p53 represses c-Myc through induction of the tumor suppressor miR-145 , 2009, Proceedings of the National Academy of Sciences.

[106]  Claire K. Inman,et al.  The Osteoblast Transcription Factor Runx2 Is Expressed in Mammary Epithelial Cells and Mediates osteopontin Expression* , 2003, Journal of Biological Chemistry.

[107]  L. Kiesel,et al.  Targeting of syndecan‐1 by microRNA miR‐10b promotes breast cancer cell motility and invasiveness via a Rho‐GTPase‐ and E‐cadherin‐dependent mechanism , 2012, International journal of cancer.

[108]  M. Biffoni,et al.  A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis , 2008, Nature Cell Biology.

[109]  M. Emmert-Buck,et al.  Current molecular diagnostics of breast cancer and the potential incorporation of microRNA , 2009, Expert review of molecular diagnostics.

[110]  A. Krogh,et al.  Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[111]  C. Benz,et al.  Rapid alteration of microRNA levels by histone deacetylase inhibition. , 2006, Cancer research.

[112]  N. Selvamurugan,et al.  MicroRNAs: Synthesis, Gene Regulation and Osteoblast Differentiation. , 2013, Current issues in molecular biology.

[113]  K. Blyth,et al.  Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo. , 2006, Cancer research.

[114]  C. Benz,et al.  Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b* , 2007, Journal of Biological Chemistry.

[115]  E. Baxter,et al.  Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[116]  F. Voss,et al.  MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. , 2010, Arthritis and rheumatism.

[117]  Francesca Meloni,et al.  An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. , 2010, Blood.

[118]  Di Chen,et al.  MicroRNA‐204 Regulates Runx2 Protein Expression and Mesenchymal Progenitor Cell Differentiation , 2009, Stem cells.

[119]  S. Dangi‐Garimella,et al.  Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let‐7 , 2009, The EMBO journal.

[120]  Peter Quesenberry,et al.  MicroRNA 125a and its regulation of the p53 tumor suppressor gene , 2009, FEBS letters.

[121]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[122]  J. Steitz,et al.  Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR , 2007, Proceedings of the National Academy of Sciences.

[123]  P. Nguyen,et al.  Novel MicroRNA Prosurvival Cocktail for Improving Engraftment and Function of Cardiac Progenitor Cell Transplantation , 2011, Circulation.

[124]  S. K. Zaidi,et al.  Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. , 2008, Cancer research.

[125]  T. Buchholz.  Radiation therapy for early-stage breast cancer after breast-conserving surgery. , 2009, The New England journal of medicine.

[126]  M. Daidone,et al.  miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. , 2009, Cancer research.

[127]  Frank Speleman,et al.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis , 2010, Nature Cell Biology.

[128]  G. Nuovo,et al.  MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. , 2009, Cardiovascular research.

[129]  S. Zhang,et al.  Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[130]  Andre J. van Wijnen,et al.  A network connecting Runx2, SATB2, and the miR-23a∼27a∼24-2 cluster regulates the osteoblast differentiation program , 2010, Proceedings of the National Academy of Sciences.

[131]  Anwar Hossain,et al.  Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA , 2006, Molecular and Cellular Biology.

[132]  S Badve,et al.  Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22 , 2011, Oncogene.

[133]  F. Yu,et al.  MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival , 2012, PloS one.

[134]  H. Baloglu,et al.  MicroRNA-21 as an Indicator of Aggressive Phenotype in Breast Cancer , 2013, Oncology Research and Treatment.

[135]  Lara J. Monteiro,et al.  Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. , 2009, Cancer research.

[136]  Aamir Ahmad,et al.  The Role of MicroRNAs in Breast Cancer Migration, Invasion and Metastasis , 2012, International journal of molecular sciences.

[137]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[138]  Domenico Coppola,et al.  MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA , 2008, Molecular and Cellular Biology.

[139]  Zhihua Liu,et al.  MicroRNA-10b Promotes Migration and Invasion through KLF4 in Human Esophageal Cancer Cell Lines* , 2010, The Journal of Biological Chemistry.

[140]  Guohua Wang,et al.  Estradiol-regulated microRNAs control estradiol response in breast cancer cells , 2009, Nucleic acids research.

[141]  Yan Zhang,et al.  Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth , 2011, Breast Cancer Research.

[142]  Brigitte Rack,et al.  Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer , 2010, Breast Cancer Research.

[143]  A. Reitmair,et al.  Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology , 2013, International journal of molecular sciences.

[144]  M. Sinha,et al.  Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP. , 2010, Biochemical and biophysical research communications.

[145]  Xiang-hang Luo,et al.  A Runx2/miR-3960/miR-2861 Regulatory Feedback Loop during Mouse Osteoblast Differentiation* , 2011, The Journal of Biological Chemistry.

[146]  Robert A. Weinberg,et al.  A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .

[147]  Ruotian Li,et al.  MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. , 2010, American journal of obstetrics and gynecology.

[148]  G. Stein,et al.  Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression. , 2009, Cancer research.

[149]  Brian D Athey,et al.  New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites. , 2009, Genome research.

[150]  X. Zhang,et al.  MiR-155 at the heart of oncogenic pathways , 2014, Oncogene.

[151]  R. Russell,et al.  Principles of MicroRNA–Target Recognition , 2005, PLoS biology.

[152]  Debmalya Barh,et al.  Let-7, miR-125, miR-205, and miR-296 are prospective therapeutic agents in breast cancer molecular medicine , 2008 .

[153]  Binbin Lu,et al.  miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2. , 2013, Biochemical and biophysical research communications.

[154]  Expression of miR-206 during the initiation of mammary gland development , 2013, Cell and Tissue Research.

[155]  Anwar Hossain,et al.  Mir-17-5 p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB 1 mRNA , 2006 .

[156]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[157]  William R Sellers,et al.  The biology and clinical relevance of the PTEN tumor suppressor pathway. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[158]  S. Schokrpur,et al.  Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells , 2008, Oncogene.

[159]  A. Børresen-Dale,et al.  Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines , 2009, Oncogene.

[160]  Yan Zeng,et al.  Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol. , 2010, Carcinogenesis.

[161]  A. Lal,et al.  MicroRNAs and their target gene networks in breast cancer , 2010, Breast Cancer Research.

[162]  Hong Guo,et al.  Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. , 2009, The Journal of infectious diseases.

[163]  G. Mills,et al.  miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells , 2010, Cell Death and Differentiation.

[164]  S. Moore.  Managing treatment side effects in advanced breast cancer. , 2007, Seminars in oncology nursing.

[165]  B. White,et al.  The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor-α (ERα) and Represses ERα Messenger RNA and Protein Expression in Breast Cancer Cell Lines , 2007 .

[166]  A. Pasquinelli,et al.  Genes and Mechanisms Related to RNA Interference Regulate Expression of the Small Temporal RNAs that Control C. elegans Developmental Timing , 2001, Cell.

[167]  Jie Zhou,et al.  microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling , 2010, Proceedings of the National Academy of Sciences.

[168]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[169]  J. Lieberman,et al.  Conserved Regulation of p53 Network Dosage by MicroRNA–125b Occurs through Evolving miRNA–Target Gene Pairs , 2011, PLoS genetics.

[170]  Stefan Wiemann,et al.  MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C ϵ (PKCϵ)* , 2013, The Journal of Biological Chemistry.

[171]  G. Kong,et al.  Loss of the polycomb protein Mel-18 enhances the epithelial–mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer , 2014, Oncogene.

[172]  S. Inoue,et al.  Runx2 in human breast carcinoma: its potential roles in cancer progression , 2010, Cancer science.

[173]  K. Chiu,et al.  Concordant and Discordant Regulation of Target Genes by miR-31 and Its Isoforms , 2013, PloS one.

[174]  H. Kitayama,et al.  Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs , 2010, Oncogene.

[175]  Tsung-Cheng Chang,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.

[176]  Karen D. Cowden Dahl,et al.  The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. , 2009, Neoplasia.

[177]  T. Guise,et al.  Therapeutic strategies to target TGF-β in the treatment of bone metastases. , 2011, Current pharmaceutical biotechnology.

[178]  N. Voirin,et al.  Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype , 2009, British Journal of Cancer.

[179]  W. Gao,et al.  Roles of microRNAs during prostatic tumorigenesis and tumor progression , 2014, Oncogene.

[180]  M. Lisanti,et al.  c-Myc induction of programmed cell death may contribute to carcinogenesis , 2011, Cancer biology & therapy.

[181]  Wayne Tam,et al.  Reticuloendotheliosis Virus Strain T Induces miR-155, Which Targets JARID2 and Promotes Cell Survival , 2009, Journal of Virology.